Ares Financial Consulting’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67K Hold
51
﹤0.01% 929
2026
Q1
$1.81K Buy
+51
New +$2.08K ﹤0.01% 858

Other funds holding CNMD

Ares Financial Consulting's CNMD Position: Q2 2026 in Review

Ares Financial Consulting held its CONMED (CNMD) position steady in Q2 2026 at 51 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #929.

Ares Financial Consulting first reported a position in CNMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.81K in Q1 2026. 78 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Ares Financial Consulting held 51 shares of CONMED worth $1.67K as of Q2 2026.
  • Ares Financial Consulting left its CONMED share count unchanged in Q2 2026.
  • CONMED made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #929 holding.
  • Ares Financial Consulting first reported a position in CONMED in Q1 2026 and has held it in 2 quarters since.
  • Ares Financial Consulting's CONMED position peaked at $1.81K in Q1 2026.
  • 78 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.